Aaron Ondrey - Sep 8, 2023 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Interim CFO
Signature
/s/ John Moriarty, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Sep 8, 2023
Transactions value $
$299,972
Form type
4
Date filed
9/12/2023, 05:30 PM
Next filing
Jan 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $300K +8.41K +59.97% $35.66 22.4K Sep 8, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a Performance Share Unit Award and shares shall vest in full on the earlier of (i) 90 days following commencement of employment of a permanent CFO, (ii) involuntary termination of employment (not for Cause).